OpenAI said Tuesday that it has released an AI “classifier” for identifying AI-authored text written by AI like its own ChatGPT. The problem? ChatGPT is pretty good at evading OpenAI’s new tool.

A systematic review found that genomic classifier tests can influence risk assessments and treatment decisions among patients with localized prostate cancer but studies evaluating these tests vary ...

Many people living with dementia never receive an accurate diagnosis, in part because Alzheimer's disease, Parkinson's ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

OpenAI, the company behind ChatGPT has launched a new AI classifier tool to determine if a text has been written by a person or by Artificial Intelligence. The tool comes with the caveat that it is ...

Making a personalized T cell therapy for cancer patients currently takes at least six months. Scientists have shown that the laborious first step of identifying tumor-reactive T cell receptors for ...